Le Pendu J - Search Results

1

[Characterization of autoantigen (p105) in a model of colonic adenocarcinoma in the rat].

Blottière HM, Ménoret A, Burg C, Douillard JY, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: le pendu j. Bull Cancer. 1992;79(1):47-53. Bull Cancer. 1992. PMID: 1520951 French.

2

Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxicity.

Blottière HM, Burg C, Zennadi R, Perrin P, Blanchardie P, Bara J, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: le pendu j. Int J Cancer. 1992 Oct 21;52(4):609-18. doi: 10.1002/ijc.2910520420. Int J Cancer. 1992. PMID: 1399144

3

Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma.

Zennadi R, Garrigue L, Ringeard S, Ménoret A, Blanchardie P, Le Pendu J. Zennadi R, et al. Among authors: le pendu j. Int J Cancer. 1992 Dec 2;52(6):934-40. doi: 10.1002/ijc.2910520618. Int J Cancer. 1992. PMID: 1459734

4

Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines.

Blottière HM, Zennadi R, Burg C, Douillard JY, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: le pendu j. Int J Cancer. 1992 Feb 20;50(4):659-64. doi: 10.1002/ijc.2910500430. Int J Cancer. 1992. PMID: 1537634

5

Identification and characterization of a rat protein (p 105) auto-antigenic in rats bearing a progressive syngeneic colon carcinoma.

Blottière HM, Menoret A, Burg C, Douillard JY, Le Pendu J. Blottière HM, et al. Among authors: le pendu j. Int J Cancer. 1992 Jan 21;50(2):315-20. doi: 10.1002/ijc.2910500225. Int J Cancer. 1992. PMID: 1730526

6

Analysis of the state of differentiation of two rat colon carcinoma clones with distinct tumorigenic properties.

Blottière HM, Ménoret A, Grégoire M, Douillard JY, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: le pendu j. Biol Cell. 1991;72(3):239-47. Biol Cell. 1991. PMID: 1794065

7

Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas.

Ménoret A, Patry Y, Burg C, Le Pendu J. Ménoret A, et al. Among authors: le pendu j. J Immunol. 1995 Jul 15;155(2):740-7. J Immunol. 1995. PMID: 7608552

8

Failure of monoclonal antibodies against tumor associated antigens to improve tumor targeting of LAK cells in a model of rat colon carcinoma.

Zennadi R, Blottière MH, Burg C, Le Pendu J, Douillard JY. Zennadi R, et al. Among authors: le pendu j. Bull Cancer. 1993 Aug;80(8):674-9. Bull Cancer. 1993. PMID: 8204947

9

Expression of the 100-kda glucose-regulated protein (GRP100/endoplasmin) is associated with tumorigenicity in a model of rat colon adenocarcinoma.

Ménoret A, Meflah K, Le Pendu J. Ménoret A, et al. Among authors: le pendu j. Int J Cancer. 1994 Feb 1;56(3):400-5. doi: 10.1002/ijc.2910560319. Int J Cancer. 1994. PMID: 8314328

10

Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.

Blottière HM, Zennadi R, Grégoire M, Aillet G, Denis MG, Meflah K, Le Pendu J. Blottière HM, et al. Among authors: le pendu j. Int J Cancer. 1993 Feb 1;53(3):409-17. doi: 10.1002/ijc.2910530311. Int J Cancer. 1993. PMID: 8428794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters